Asset Details
Do you wish to reserve the book?
Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance
Do you wish to request the book?
Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance
2021
Overview
Recent developments of organoids engineering and organ-on-a-chip microfluidic technologies have enabled the recapitulation of the major functions and architectures of microscale human tissue, including tumor pathophysiology. Nevertheless, there remain challenges in recapitulating the complexity and heterogeneity of tumor microenvironment. The integration of these engineering technologies suggests a potential strategy to overcome the limitations in reconstituting the perfusable microvascular system of large-scale tumors conserving their key functional features. Here, we review the recent progress of in vitro tumor-on-a-chip microfluidic technologies, focusing on the reconstruction of microvascularized organoid models to suggest a better platform for personalized cancer medicine.
Publisher
Springer Nature B.V
Subject
